查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1836368

2032 年生理食盐水市场预测：按产品类型、包装类型、分销管道、应用、最终用户和地区进行分析

Physiological Saline Market Forecasts to 2032 - Global Analysis By Product Type (Normal Saline, Hypertonic Saline, Hypotonic Saline, Buffered Saline, and Other Product Types), Packaging Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生理食盐水市场预计在 2025 年达到 57 亿美元，到 2032 年将达到 103.6 亿美元，预测期内的复合年增长率为 8.9%。

生理食盐水水（普通生理食盐水）是一种浓度为0.9%的无菌氯化钠溶液，其浓度反映人体血液和组织中的盐浓度。它在医疗保健领域广泛用于静脉注射、伤口冲洗、洗眼以及作为药物载体。其等渗性有助于维持细胞完整性、促进水合作用并确保电解质平衡，使其成为各种临床应用的必需品。

根据 2024 年手术统计报告，2024 年共进行了约 1,585,878 例整容手术，与 2023 年相比增加了 1%。

手术和医疗程序数量增加

外科手术和医疗干预的频率不断增加，大大推动了对生理食盐水的需求。随着糖尿病、心血管疾病和癌症等慢性疾病的日益普遍，医院在进行越来越多的手术时需要使用生理食盐水进行补充液体、冲洗和药物稀释。微创和机器人辅助手术的技术进步进一步增加了手术室中生理食盐水的使用量。人口老化和诊断能力的提高导致全球住院率上升。生理食盐水也被纳入个人化治疗方法，特别是在术后护理和静脉治疗。手术量的激增使盐水成为现代临床工作流程的重要组成部分。

供应链脆弱性和短缺

医用级塑胶和无菌包装材料的供应有限，影响了生产计画。製造商越来越多地采用预测分析和数位物流平台来管理库存并减少延误。然而，区域性停工、劳动力限制和运输瓶颈持续给分销网络带来压力。规模较小的生产商往往难以采购原材料并保持合规性，从而降低了应对力。如果没有完善的应急计划，医院和家庭护理机构将面临供应不稳定的风险。

在生物製药和注射药物传输的应用日益增多

生理食盐水水作为生物製药製剂和注射疗法的载体溶液正日益受到欢迎。其与生技药品的高度相容性以及在药物传输系统中的稳定性使其成为静脉注射和皮下注射的理想选择。单株抗体、疫苗和生物相似药的兴起推动了临床试验和商业生产中对无菌生理食盐水生理食盐水的需求。预填充式注射器和自动注射器的技术创新正在扩大生理食盐水水在以病人为中心的药物传递中的作用。单剂量包装和无菌製程的监管支持正在鼓励其更广泛地应用。这一趋势为生理食盐水水製造商与製药公司合作并投资先进灌装技术开闢了新的途径。

塑胶包装的环境问题

生理食盐水水塑胶包装的广泛使用引发了人们对环境永续性的担忧。一次性生理食盐水水袋和瓶的处理增加了医疗废弃物的产生，引发了监管机构和环保组织的关注。製造商正在探索可生物降解的聚合物和可回收的包装，以减少对生态系统的影响。轻质软包装袋和可重复使用的输送系统等新技术正日益受到关注。医院也正在采用注重环保的采购政策，并更倾向选择环保供应商。如果不优先考虑永续性措施，市场可能面临监管压力和声誉风险。

COVID-19的影响：

新冠疫情扰乱了生理食盐水食盐水供应链，导致择期手术延误，医院资源紧张。封锁措施导致生产延误和物流挑战，最终导致必要生理食盐水食盐水短缺。然而，这场危机加速了医疗保健的数位转型，包括远端监控和远端医疗，间接增加了家庭生理食盐水疗法的需求。紧急核准和快速监管途径有助于在需求尖峰时段保持供应连续性。疫情后的策略如今强调分散式生产、自动化和弹性采购模式。

预计生理食盐水水市场在预测期内将占最大份额

由于其广泛的临床效用，预计生理食盐水水将在预测期内占据最大的市场份额。生理食盐水水广泛用于静脉补液、伤口冲洗、注射药物的稀释剂。它在医院和诊所的常规手术、紧急手术和术后恢復中使用。无菌填充和包装技术的进步提高了保质期和安全性。门诊和家庭输液的增加进一步推动了对即用型生理食盐水水的需求。由于医疗保健系统优先考虑具有成本效益和多功能的解决方案，生理食盐水水仍然是输液治疗的基石。

预计家庭医疗保健领域在预测期内将实现最高复合年增长率

预计居家医疗领域将在预测期内实现最高成长率。患者越来越偏好在家治疗，尤其是慢性病治疗，这推动了对携带式生理食盐水输送系统的需求。穿戴式输液帮浦和预填充生理食盐水水套件等技术创新正在提高便利性和依从性。与远端医疗的结合使得生理食盐水给药能够进行远端监控，从而提高安全性和疗效。报销支持和人口老化进一步推动了该领域的扩张。随着治疗从医院转向家庭，盐水输送正成为分散式照护模式不可或缺的一部分。

比最大的地区

预计亚太地区将在预测期内占据最大的市场份额，这得益于其医疗基础设施的快速发展。中国、印度和日本等国正大力投资医院扩建和医疗设备製造。政府推动本地生产和进口替代的措施正在加强该地区的供应链。机器人手术和基于人工智慧的诊断技术的采用，正在增加生理食盐水在先进手术中的使用。全球和本地公司之间的策略联盟正在加强技术转移和市场渗透。由于患者人数众多且手术量不断增长，该地区已成为重要的成长引擎。

复合年增长率最高的地区：

在预测期内，由于技术创新和强劲的研发投入，北美预计将实现最高的复合年增长率。美国和加拿大在智慧输液系统、自动配药和人工智慧病患监测处于领先地位。监管机构正在简化下一代生理食盐水包装和配送方式的核准。医院正在采用物联网支援的库存系统，以优化生理食盐水使用并减少浪费。优惠的报销政策和居家照护的普及率正在推动市场成长。随着精准医疗和个人化治疗的发展势头强劲，北美将继续成为生理食盐水创造新的标竿。

免费客製化服务：

此报告的订阅者可以使用以下免费自订选项之一：

  • 公司简介
    • 对最多三家其他市场公司进行全面分析
    • 主要企业的SWOT分析（最多3家公司）
  • 区域细分
    • 根据客户兴趣对主要国家进行的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 数据分析
    • 数据检验
    • 研究途径
  • 研究材料
    • 主要研究资料
    • 次级研究资讯来源
    • 先决条件

第三章市场走势分析

  • 驱动程式
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19的影响

第四章 波特五力分析

  • 供应商的议价能力
  • 买方的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争对手之间的竞争

5. 全球生理食盐水市场（依产品类型）

  • 生理食盐水
  • 高渗透压盐水
  • 低渗盐水
  • 缓衝生理食盐水
  • 其他产品类型

6. 全球生理食盐水水市场（依包装类型）

  • 宝特瓶
  • 玻璃瓶
  • 袋/包
  • 预填充式注射器

7. 全球生理食盐水水市场（依通路）

  • 医院药房
  • 网路药局
  • 零售药局

8. 全球生理食盐水水市场（依应用）

  • 静脉治疗
  • 透析
  • 创伤护理和清洁
  • 实验室使用
  • 眼科
  • 其他用途

9. 全球生理食盐水水市场（以最终用户划分）

  • 医院和诊所
  • 门诊手术中心
  • 研究和学术机构
  • 家庭医疗保健
  • 其他最终用户

第 10 章全球生理食盐水市场（按地区）

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲地区

第十一章 重大进展

  • 协议、伙伴关係、合作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第 12 章：公司概况

  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Fresenius Kabi
  • ICU Medical, Inc.
  • Pfizer Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Grifols, SA
  • Terumo Corporation
  • Sichuan Kelun Pharmaceutical
  • SSY Group Ltd.
  • Cisen Pharmaceutical Co., Ltd.
  • Nipro Corporation
  • Amsino International, Inc.
  • Medline Industries, LP.
  • Double-Crane Pharmaceutical Co., Ltd.
Product Code: SMRC31492

According to Stratistics MRC, the Global Physiological Saline Market is accounted for $5.70 billion in 2025 and is expected to reach $10.36 billion by 2032 growing at a CAGR of 8.9% during the forecast period. Physiological saline, or normal saline, is a sterile 0.9% sodium chloride solution that mirrors the salt concentration found in human blood and tissues. It is widely used in healthcare for intravenous therapy, cleaning wounds, eye washes, and as a carrier for drugs. Being isotonic, it preserves cellular integrity, aids hydration, and ensures electrolyte balance, making it essential for various clinical applications.

According to the 2024 Procedural Statistics Release, approximately 1,585,878 cosmetic surgeries were performed in 2024, representing a 1% increase compared to 2023, while reconstructive procedures rose by 2% during the same period, underscoring steady growth in surgical interventions.

Market Dynamics:

Driver:

Rising volume of surgical and medical procedures

The increasing frequency of surgical and medical interventions is significantly boosting the demand for physiological saline solutions. As chronic illnesses like diabetes, cardiovascular conditions, and cancer become more prevalent, hospitals are performing more procedures that require saline for hydration, irrigation, and drug dilution. Technological advancements in minimally invasive and robotic-assisted surgeries are further amplifying saline usage across operating rooms. Aging populations and improved diagnostic capabilities are contributing to higher hospitalization rates globally. Saline is also being integrated into personalized treatment regimens, especially in post-operative care and intravenous therapies. This surge in procedural volume is positioning physiological saline as a critical component in modern clinical workflows.

Restraint:

Supply chain vulnerabilities and shortages

Disruptions in the availability of medical-grade plastics and sterile packaging materials have impacted production timelines. Manufacturers are increasingly adopting predictive analytics and digital logistics platforms to manage inventory and mitigate delays. However, regional lockdowns, labor constraints, and transportation bottlenecks continue to strain distribution networks. Smaller producers often struggle with sourcing raw materials and maintaining regulatory compliance, slowing market responsiveness. Without robust contingency strategies, the industry risks inconsistent supply to hospitals and home care providers.

Opportunity:

Increasing Use in biopharmaceuticals and injectable drug delivery

Physiological saline is gaining traction as a carrier solution in biopharmaceutical formulations and injectable therapies. Its compatibility with biologics and stability in drug delivery systems make it ideal for intravenous and subcutaneous applications. The rise of monoclonal antibodies, vaccines, and biosimilars is driving demand for sterile saline in clinical trials and commercial production. Innovations in pre-filled syringes and auto-injectors are expanding saline's role in patient-centric drug administration. Regulatory support for single-dose packaging and aseptic processing is encouraging broader adoption. This trend opens new avenues for saline manufacturers to collaborate with pharma companies and invest in advanced filling technologies.

Threat:

Environmental concerns over plastic packaging

The widespread use of plastic containers for saline solutions is raising environmental sustainability concerns. Disposal of single-use saline bags and bottles contributes to medical waste, prompting scrutiny from regulators and environmental groups. Manufacturers are exploring biodegradable polymers and recyclable packaging to reduce ecological impact. Emerging technologies like lightweight flexible pouches and reusable delivery systems are gaining attention. Hospitals are also adopting green procurement policies, favoring suppliers with eco-friendly credentials. If sustainability measures are not prioritized, the market may face regulatory pressure and reputational risks.

Covid-19 Impact:

The COVID-19 pandemic disrupted the physiological saline supply chain, delaying elective procedures and straining hospital resources. Lockdowns led to manufacturing slowdowns and logistical challenges, resulting in shortages of essential saline products. However, the crisis accelerated digital transformation in healthcare, including remote monitoring and telemedicine, which indirectly increased demand for home-based saline therapies. Emergency approvals and fast-track regulatory pathways helped maintain supply continuity during peak demand. Post-pandemic strategies now emphasize decentralized production, automation, and resilient sourcing models.

The normal saline segment is expected to be the largest during the forecast period

The normal saline segment is expected to account for the largest market share during the forecast period, due to its broad clinical utility. It is widely used for intravenous hydration, wound irrigation, and as a diluent for injectable drugs. Hospitals and clinics rely on it for routine procedures, emergency care, and post-operative recovery. Technological advancements in sterile filling and packaging have improved shelf life and safety. The rise in outpatient treatments and home infusions is further boosting demand for ready-to-use saline formats. As healthcare systems prioritize cost-effective and versatile solutions, normal saline remains the cornerstone of fluid therapy.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate. Increasing patient preference for at-home treatments, especially for chronic conditions, is driving demand for portable saline delivery systems. Innovations in wearable infusion pumps and pre-filled saline kits are enhancing convenience and compliance. Telehealth integration allows remote monitoring of saline administration, improving safety and outcomes. Reimbursement support and aging populations are further propelling this segment's expansion. As care shifts from hospitals to homes, physiological saline is becoming essential in decentralized treatment models.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, driven by rapid healthcare infrastructure development. Countries like China, India, and Japan are investing heavily in hospital expansion and medical device manufacturing. Government initiatives promoting local production and import substitution are strengthening regional supply chains. Adoption of robotic surgeries and AI-based diagnostics is increasing saline usage in advanced procedures. Strategic collaborations between global players and local firms are enhancing technology transfer and market penetration. The region's large patient base and rising surgical volumes make it a key growth engine.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fueled by innovation and strong R&D investment. The U.S. and Canada are leading in smart infusion systems, automated compounding, and AI-driven patient monitoring. Regulatory bodies are streamlining approvals for next-gen saline packaging and delivery formats. Hospitals are adopting IoT-enabled inventory systems to optimize saline usage and reduce waste. Favorable reimbursement policies and high adoption of home-based care are accelerating market growth. As precision medicine and personalized therapies gain momentum, North America continues to set the benchmark for saline innovation.

Key players in the market

Some of the key players in Physiological Saline Market include Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi, ICU Medical, Inc., Pfizer Inc., Otsuka Pharmaceutical Co., Ltd., Grifols, S.A., Terumo Corporation, Sichuan Kelun Pharmaceutical, SSY Group Ltd., Cisen Pharmaceutical Co., Ltd., Nipro Corporation, Amsino International, Inc., Medline Industries, L., and Double-Crane Pharmaceutical Co., Ltd.

Key Developments:

In September 2025, Baxter International Inc. launched the Welch Allyn Connex 360 Vital Signs Monitor, its next generation patient monitoring device. As the latest innovation in Baxter's connected monitoring portfolio, Connex 360 offers an advanced connectivity and security platform, customizable configurations based on a hospital's clinical routines, and upgrade capabilities that set the stage for future functionality and enhancements.

In September 2025, B. Braun SE announced the full acquisition of True Digital Surgery (TDS), a company based in Goleta, California, specializing in digital robotic-assisted 3D surgical microscopy. This acquisition highlights B. Braun's commitment to investing in the future of digital microsurgery and to expanding its market share in this growing segment.

Product Types Covered:

  • Normal Saline
  • Hypertonic Saline
  • Hypotonic Saline
  • Buffered Saline
  • Other Product Types

Packaging Types Covered:

  • Plastic Bottles
  • Glass Bottles
  • Pouches/Bags
  • Pre-filled Syringes

Distribution Channels Covered:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies

Applications Covered:

  • Intravenous Therapy
  • Dialysis
  • Wound Care & Irrigation
  • Laboratory Use
  • Ophthalmology
  • Other Applications

End Users Covered:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Research & Academic Institutes
  • Home Healthcare
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Physiological Saline Market, By Product Type

  • 5.1 Introduction
  • 5.2 Normal Saline
  • 5.3 Hypertonic Saline
  • 5.4 Hypotonic Saline
  • 5.5 Buffered Saline
  • 5.6 Other Product Types

6 Global Physiological Saline Market, By Packaging Type

  • 6.1 Introduction
  • 6.2 Plastic Bottles
  • 6.3 Glass Bottles
  • 6.4 Pouches/Bags
  • 6.5 Pre-filled Syringes

7 Global Physiological Saline Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Online Pharmacies
  • 7.4 Retail Pharmacies

8 Global Physiological Saline Market, By Application

  • 8.1 Introduction
  • 8.2 Intravenous Therapy
  • 8.3 Dialysis
  • 8.4 Wound Care & Irrigation
  • 8.5 Laboratory Use
  • 8.6 Ophthalmology
  • 8.7 Other Applications

9 Global Physiological Saline Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals & Clinics
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Research & Academic Institutes
  • 9.5 Home Healthcare
  • 9.6 Other End Users

10 Global Physiological Saline Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Baxter International Inc.
  • 12.2 B. Braun Melsungen AG
  • 12.3 Fresenius Kabi
  • 12.4 ICU Medical, Inc.
  • 12.5 Pfizer Inc.
  • 12.6 Otsuka Pharmaceutical Co., Ltd.
  • 12.7 Grifols, S.A.
  • 12.8 Terumo Corporation
  • 12.9 Sichuan Kelun Pharmaceutical
  • 12.10 SSY Group Ltd.
  • 12.11 Cisen Pharmaceutical Co., Ltd.
  • 12.12 Nipro Corporation
  • 12.13 Amsino International, Inc.
  • 12.14 Medline Industries, LP.
  • 12.15 Double-Crane Pharmaceutical Co., Ltd.

List of Tables

  • Table 1 Global Physiological Saline Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Physiological Saline Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Physiological Saline Market Outlook, By Normal Saline (2024-2032) ($MN)
  • Table 4 Global Physiological Saline Market Outlook, By Hypertonic Saline (2024-2032) ($MN)
  • Table 5 Global Physiological Saline Market Outlook, By Hypotonic Saline (2024-2032) ($MN)
  • Table 6 Global Physiological Saline Market Outlook, By Buffered Saline (2024-2032) ($MN)
  • Table 7 Global Physiological Saline Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 8 Global Physiological Saline Market Outlook, By Packaging Type (2024-2032) ($MN)
  • Table 9 Global Physiological Saline Market Outlook, By Plastic Bottles (2024-2032) ($MN)
  • Table 10 Global Physiological Saline Market Outlook, By Glass Bottles (2024-2032) ($MN)
  • Table 11 Global Physiological Saline Market Outlook, By Pouches/Bags (2024-2032) ($MN)
  • Table 12 Global Physiological Saline Market Outlook, By Pre-filled Syringes (2024-2032) ($MN)
  • Table 13 Global Physiological Saline Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 14 Global Physiological Saline Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 15 Global Physiological Saline Market Outlook, By Online Pharmacies (2024-2032) ($MN)
  • Table 16 Global Physiological Saline Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 17 Global Physiological Saline Market Outlook, By Application (2024-2032) ($MN)
  • Table 18 Global Physiological Saline Market Outlook, By Intravenous Therapy (2024-2032) ($MN)
  • Table 19 Global Physiological Saline Market Outlook, By Dialysis (2024-2032) ($MN)
  • Table 20 Global Physiological Saline Market Outlook, By Wound Care & Irrigation (2024-2032) ($MN)
  • Table 21 Global Physiological Saline Market Outlook, By Laboratory Use (2024-2032) ($MN)
  • Table 22 Global Physiological Saline Market Outlook, By Ophthalmology (2024-2032) ($MN)
  • Table 23 Global Physiological Saline Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 24 Global Physiological Saline Market Outlook, By End User (2024-2032) ($MN)
  • Table 25 Global Physiological Saline Market Outlook, By Hospitals & Clinics (2024-2032) ($MN)
  • Table 26 Global Physiological Saline Market Outlook, By Ambulatory Surgical Centers (2024-2032) ($MN)
  • Table 27 Global Physiological Saline Market Outlook, By Research & Academic Institutes (2024-2032) ($MN)
  • Table 28 Global Physiological Saline Market Outlook, By Home Healthcare (2024-2032) ($MN)
  • Table 29 Global Physiological Saline Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.